A B S T R A C T A highly specific antiserum to 3,3',5'-triiodothyronine (reverse T3, rTs) was prepared by immunization of rabbits with DL-rT3-human serum albumin conjugate. Of the various thyroid hormone derivatives tested, only 3,3'-diiodothyronine (3,3'-T2) 
munization of rabbits with DL-rT3-human serum albumin conjugate. Of the various thyroid hormone derivatives tested, only 3,3'-diiodothyronine (3,3'-T2) crossreacted significantly (10%) with rT3-binding sites on the antiserum, while thyroxine (T4) and triiodothyronine (T3) cross-reacted by less than 0.1%. The circulate in low levels. (c) Cross-reaction of T4 in rT3 RIA of 0.06% although small, could contribute to RIA estimates of rT3; the effect of T4 would be particularly important in case of serum of hyperthyroid patients. Thus, serum rT3 concentration in hyperthyroid patients averaged 89±48 Ag/100 ml after correction for cross-reaction effects of T4; this value was about 14% lower than that before correction (see above).
Serum rT3 concentartion in cord sera of seven newborns averaged 136±19 ng/100 ml; it was clearly elevated and within the range of values seen in hyperthyroid patients. This was the case when the mean T4 concentration in the newborn cord sera was moderately higher than normal and about one-half that in hyperthyroid patients, whereas serum T3 was markedly below the normal adult level. A Pronase hydrolysate of thyroglobulin prepared from pooled normal thyroid glands contained 0.042, 3.0, and 0. 16 Ag/mg protein of rT3, T4, and TI, respectively. The various data suggest that: (a) rTa is a normal component of human serum and thyroglobulin: (b) peripheral metabolism of T4 is an important source of the rT3 present in serum; (c) peripheral conversionINTRODUCTION On the basis of recent studies of the metabolism of radioactive thyroxine (T4), it has been proposed that iodine atoms from both the phenolic and tyrosyl rings of this molecule are removed randomly at a similar rate, resulting in the formation of 3, 5, 3'-triiodothyronine (T3),1 when monodeiodination occurs first in the phenolic ring, or of 3, 3',5'-triiodothyronine (reverse T3, rT3), when monodeiodination occurs first in the tyrosyl ring (1) . While several studies have provided data which have clearly established that T4 is indeed an important source of the body pool of T3 both in man and in experimental animals, (2) (3) (4) (5) (6) (7) (8) , there is a paucity of data on rT3. Thus, we do not know if it actually exists in normal man and, if so, what its sources may be. rT3 has been identified both in serum and thyroglobulin (Tg) of the rat (9, 10). However, there are apparently some important differences in the metabolism of rT3 in the rat and in man. Thus, whereas the urinary and fecal excretion of injected radioactive rT3 in the rat are very similar to that of radioactive T4 (11) , rT3 is metabolized in man much faster than either T4 or T3 (12) . Markedly rapid metabolism of rT3 has led to the consideration that rT3 may not exist naturally in man (12) . Because of the apparent importance of these issues to an understanding of the metabolism of T4 in man (1, 8, 13, 14) , I undertook to develop a radioimmunoassay (RIA) method for its measurement in serum, which is described in this report. The data obtained with this method indicate not only that rT3 is normally present in the circulation of man but also that significant alterations do occur in its serum level in various thyroid diseases. These studies also suggest that T4 is an important source of rT3 in serum. in dilution of 1:250. The bound to free ratio so obtained has been noted to be optimal for the sensitivity of RIAs (17) .
METHODS

Reagents. D, L-
RIA procedure. In 10 X 75-mm disposable glass culture tubes, the various reagents were added in the following order: (a) 0.075 M barbital buffer containing 1% normal rabbit serum and 0.01% sodium azide (barbital buffer), adjusted to a final volume of 1 ml. Subsequent experiments indicated that PBS could be substituted for barbital buffer without an appreciable difference in the results. Preparation of extracts of test sera. 0.5 ml of serum was mixed with 1 ml of 95% ethanol on. a vortex mixer. The mixture was centrifuged at 1,000 g for 10 min to sediment precipitated proteins. A 300-1l aliquot of the supernate was used directly for rT3 assay.
Sources of sera. Serum was obtained from 27 normal subjects, who were healthy laboratory workers or relatives of patients or hospital staff, 22 untreated hyperthyroid patients with Graves' disease, and 12 patients with primary hypothyroidism. The clinical diagnosis of Graves' disease was based on the finding in each case of a diffuse goiter, high 24-h thyroid 131I uptake, and elevated serum T4 and T3 concentrations as determined by RIAs (19, 20) . Hypothyroidism was diagnosed on the basis of clinical examination, low serum T4, and elevated serum thyrotropin (TSH) (21) . Sera were also obtained from 12 hypothyroid patients when they received treatment with synthetic T4 (Synthroid, Flint, Eaton & Co., Div. of Baxter Laboratories, Inc., Morton Grove, Ill.). Serum T4 concentration in these patients varied between 7.5 and 25 /Lg/100 ml. Sera of five patients with elevated serum concentration of thyroxinebinding globulin (TBG) were tested; two of them were in the third trimester of pregnancy, and three were receiving exogenous estrogen for contraception. Serum TBG concentration in these subjects, as determined by a competitive ligand-binding assay (22) , varied from 4.2 to 5.4 mg/100 ml (normal range 1.6-4.2). Sera were also collected from cord bloods of seven full-term fetuses at the time of vaginal delivery. Alterations in serum rT3 levels were tested in four Graves' disease patients receiving treatment with propylthiouracil. Additionally, serum rTs levels were measured throughout a day in hypothyroid patients receiving a daily dose of thyroid hormones; two of these patients received Synthroid, 0.2 and 0.3 mg, and two others Ts (Cytomel, Smith, Kline & French Laboratories, Philadelphia, Pa.), 75 and 100 Ag. Blood was obtained from another patient who had allegedly ingested 900 tablets of Synthroid, 0.2 mg each, 3 days before this study. Sera were also obtained before and at periodic intervals after i.v. administration of 2 mg of rT3 dissolved in sterile salt-poor HSA (Parke, Davis & Co., Detroit, Mich.) to two normal subjects. After separation by centrifugation, sera were stored frozen at -100C.
Thyroglobulin. Thyroglobulin (Tg) was prepared from a pool of 10 apparently normal human thyroid glands obtained at autopsy; the methods of preparation have been described previously (23, 24) . Tg was hydrolyzed with Pronase (Calbiochem) under the conditions described by Inoue and Taurog (25) and used by us previously (26) . The hydrolysate was extracted with 2 vol of 95%o ethanol, and rT3 content of the extract was determined by the RIA described above. T4 and T3 content of this Tg was determined by RIA (26, 27 (Fig. 1) . This amount of T4 would be expected in 100 Al of serum, tested routinely, only when the serum T4 concentration is 15 tg/100 ml or higher.
Comparison of samples with standards. The doseresponse curves of inhibition of the binding of ['I]rT3 to antibody produced by the ethanol extracts of serum of one newborn and a hyperthyroid patient, diluted in 63% ethanol, have been compared with the regular standard curve of rT3 assay in Fig. 2 ; the final ethanol concentration was constant at 19% at each point. The various dose-response curves were essentially parallel. Similarly parallel dose-response curves were observed with extracts of the sera of another newborn another hyperthyroid patient, and two normal subjects. Also shown in Fig. 2 Effect of addition of T4 on serum rTs concentration. Although cross-reaction studies had shown that To would have little interference in the rT3 assay, the effect of addition of T4 to serum on immunoassayable rT3 was studied. A T4 preparation, which had shown 0.06% cross-reactivity in the rT3 assay, was added in concentrations varying between 15 and 100 tug/100 ml to sera with variable rT3 concentration. The data on serum rT3 levels measured in these sera are shown in Table III . It is apparent that addition of this T4 to serum does not increase the rT, estimated by the RIA by any more than the 0.06% expected from studies of specificity of RIA.
Recovery experiments. The mean recovery of radioactive rT3 added to 10 sera was 89±1.5% 2 (range 84-94). Recovery did not vary systematically in sera from different classes of patients. In separate experiments, mean recovery of nonradioactive rT3 added to ethanol extracts of a pooled serum from hospitalized patients in amounts ranging from 50 to 500 ng/100 ml was 96±0.5% for 50 ng (n = 4), 101±1.5% for 100 ng (n= 4), 994-6% for 300 ng (n = 4), and 106±3.2% for 500 ng (n = 3). The mean recovery of all 15 experiments was 101±
2 The data here and subsequently are presented as mean +SE unless specified otherwise. (4) 7 95±4 (4) <10±0 (4) 8 153±7 (4) <10±0 (4) * Serum rT3 concentration, mean±SD (n).
2%. The rT3 concentration in the serum extract was determined to be 54 ng/100 ml. The recovery of nonradioactive rT3 added to the same pooled serum before ethanol extraction was 96±2% for 50 ng (n = 4), 91±4% for 100 ng (n= 4), 91±4% for 300 ng (n= 4), and 93± 3% for 500 ng (n = 4). The mean recovery for all 16 experiments was 93±1%.
Reproducibility. Both intra-and interassay reproducibility was examined in samples with variable rT3 concentration. The mean coefficient of variation (SD/mean X 100) for 28 samples varying in rT3 concentration from 28 to 240 ng/100 ml, each of which was tested in duplicate or quadruplicate in the same assay, was 5.6±0.8%. The mean coefficient of variation of four specimens varying in rT3 concentration from 50 to 100 ng/100 ml and assayed in duplicate two to six times in different assays was 10.3±0.8%. No systematic differences in reproducibility were noted in serum rTs values read off the various portions of the standard curve.
Serum rTs concentration in health and disease. Table IV presents data on serum rT3, T4, and T3 concentrations in normal subjects and patients with various levels of thyroid function. The mean serum rTs concentration in 27 healthy euthyroid subjects was 40.5 ng/100 ml. Nor- t Serum rT3 concentration, mean-i-SD (n).
Reverse T, Radioimmunoassay ng/100 ml, significantly greater than the normal mean value (P < 0.005). The mean serum T4 and T3 concentrations in these patients were also significantly higher than those in normal subjects. The five subjects whose serum TBG concentration was high-normal or high had a mean serum rT3 concentration of 54.2 ng/100 ml, which was significantly higher than the corresponding normal value (P < 0.01). The mean serum rT3 concentration of 136 ng/100 ml in seven newborn cord sera was also significantly higher than that in normal adults. Serum T4 concentration in the newborn was modestly higher than that in the adult. On the other hand, the mean newborn serum T3 of 24 ng/100 ml was significantly lower than the corresponding adult value. The alterations in serum rT3 and T4 concentrations were studied in four Graves' disease patients receiving treatment with propylthiouracil. Serum rT3 concentration of 65 and 58 ng/100 ml was high or high-normal, respectively, in two patients who were still hyperthyroid during the early phase of treatment; it fell to or below normal levels with continuation of therapy. Serum rT3 concentration, maintained in the normal range during antithyroid drug treatment in another two patients, increased to supranormal levels (90 and 100 ng/ 100 ml) when they became hyperthyroid four weeks after the termination of a 1-yr course of antithyroid therapy. ,Ag/100 ml, respectively, 10 min after the injection and steadily fell thereafter. The rate of disappearance of nonradioactive rT3 from serum of these patients was similar to that reported previously for the similar racemic mixture of radioactive rT3 (12) . rT3 (% dose/liter) remaining in serum 1 h after injection of rT3 was 2.4 and 2.5% in two cases in the present study, whereas it varied between 1.0 and 9.8% (mean, 4.5) in seven patients reported previously (12) . The rapid rate of disappearance of rT3 from serum in the first few hours makes it difficult to estimate the half-life of rT3 in the circulation or its volume of distribution with any degree of accuracy.
Serum rT3 concentration was measured for a day in hypothyroid patients receiving commercially available preparations of T4 and T3 for 2 wk or longer. Serum rT3 levels were normal (36-S50 ng/100 ml) throughout the day in two patients taking replacement doses of 0.2 and 0.3 ng of T4. Serum rT3 levels were 12 ng/100 ml or less during a day in two patients taking 75 and 100 Ag of T3/ day; serum T3 concentration in these patients was 495 and 1,050 ng/100 ml, respectively, 4 h after administration of T3, and gradually decreased thereafter. Serum levels rT3, T4, and T3, of 250 ng/100 ml, 83 iug/100 ml, and 2,600 ng/100 ml, respectively, in the patient (P.MI.) who had allegedly ingested 180 mg of T4 three days before study were markedly elevated; the values decreased modestly to 196 ng/100 ml, 72 Ig/100 ml, and 2,200 ng/ 100 ml, respectively, 24 h after the initial study.
Revcrse Ts, T4, and T. in niormal Tg. Reverse T3, T4, and T3 content of Tg prepared from pooled normal thyroid glands of 10 subjects was 0.042, 3.0, and 0.16 ,ug/ mg protein, respectively. The T4/rT3 ratio in this Tg was 71.4, whereas the T4/T3 ratio was 18.7.
DISCUSSION
The present studies have demonstrated that it is feasible to prepare a highly specific rT3-binding antiserum with an affinity suitable for detection of picogram quantities of nonradioactive rT3. These studies highlight again the important influence that presence of a single iodine atom in the thyronine nucleus may have on the nature of the antibodies generated by the rabbit; for example, T4 showed little cross-reaction with the rT3 antibody. In this respect, the experience with rT3 is very similar to the previous experience with T3-binding antibody (18, 19, (28) (29) (30) . In addition, however, the present stud- Of various thyroid hormone derivatives studied, only 3, 3'-T2 cross-reacted significantly (10%) with rTa antibody. This ought to be considered, however, the maximal estimate of the cross-reaction. The possibility that 3, 3'-T2 was contaminated with rTa cannot be excluded. Significant interference of 3,3'-T2 in rTa assay may also be related to the possible presence of some 3,3'-Ta antibody in the serum of rabbits immunized with rTa-HSA conjugate; this could happen if the 5' iodine of rTn were lost during the process of conjugation or if the rTa used to prepare rTa-HSA conjugate were contaminated with 3,3'-Ta. In any case, the practical significance of cross-reaction with 3,3'-T2 is difficult to assess because little information is available on its presence or concentration in human serum. It has, however, been detected in both serum and thyroid gland of the rat (9,31m) . Its turnover in man is so rapid that its presence in human serum has been considered highly unlikely (32) . In contrast with 3,3'-Ta, the effect of the cross-reaction with T4 is clearly impotrant in the rTa assay because of large amounts present in serum compared to rTa. However, the remarkably low cross-reaction of T4 with rT3 antibody held the effect of T4 on the rTa measurement to an acceptably low level. Thus, in the case of normal subjects, whose serum T.1 concentration averaged 8.6 Ag/lOO ml (Table III) , the cross-reaction of T4 with rTa antiReverse T, Radioimmunoassay .589 body of 0.06% would be expected to increase average normal serum rT3 artifactually by no more than 5.2 ng/ 100 ml. Distinct from our usual practice of using unmodified serum in RIAs of iodothyronines (19, 20) , the present study employed ethanol extracts of serum for RIA of rTs. This was done (a) because little information is currently available regarding the nature of serum protein binding of rTs and (b) on the basis of a previous report which indicated rapid metabolism of rT3 in man, we expected to find, if any, only small quantities of rT3 in serum; therefore it was felt important to devise a RIA where potential interference due to serum proteins would be minimal. The present studies have indicated that ethanol extraction is a simple and reliable procedure for extraction of rT3 from serum and that antisera can be generated that allow an accurate and precise measurement of rT3 in ethanol extracts of serum. The experience with rT3 was similar in these respects to that previously reported for RIA of T3 in serum (33, 34) .
As might have been expected from previous data in the rat and in man (1, 9, 10) , the present studies indicate that rT3 is indeed a normal constituent of human serum. The observed mean serum rT3 concentration of 41 ng/100 ml could not be attributed to a cross-reaction of T4 in the rT3 assay; this value was about seven times greater than what could be expected merely from cross-reaction of T4 (see above). However, since 3,3'-T2 cross-reacted 10% in the rT3 RIA, one could consider the estimated normal mean serum rT3 concentration of 41 ng/100 ml to be a result of the 410 ng/100 ml of 3,3'-Ta in serum.
However, this appears highly unlikely. The half-time of disappearance of 3,3'-T2 has been estimated to be 1 h or less (32) . Even if 3,3'-T2 is considered to be distributed only in the plasma volume of approximately 3 liters, a serum concentration of 410 ng/100 ml would correspond to a calculated production rate of 3,3'-T2 of about 205 pg/day, which is over twice that of T4. This could occur if 3,3'-Ta were much more abundant in the human thyroid than T. There is, however, no evidence in man or in experimental animals to favor such a consideration, nor do the studies of Tg noted here support this possibility at all (see above).
Since the D,L-rT3 used in the standards is different from the L-rT3 assumed to be present in man, it is possible that the true rT3 concentration in human serum may be somewhat different from that noted in the present study. However, a major difference is unlikely since in several studies, D-isomers of Ts and T4 have been noted to react with T3 and T4 antibodies with a potency similar to and varying between 82 and 140% that of the corresponding L-isomers (18, 19, 27, 29) . However, D-T3 reacted with one anti-T3 with a potency only 39% that L-T3 (35) . In any case, even if the D-and L-isomers of rT3 were to react differently with rT3 antibody, this would only alter the true serum concentration of L-rT3 but would not limit the interpretation of relative changes in serum rT3 in health and disease presented in this report. Serum rT3 values presented here should be interpreted to reflect relative changes in various situations rather than as absolute (true) serum rTs values also because of (a) some (0.06%) cross-reaction of T4 in rTs RIA and (b) 3,3'-T2, which cross-reacted 10% in rTs RIA. Although the latter has been considered unlikely to be present in human serum (32) , it may circulate in low levels.
To assess the sources of rT3 in human serum, we examined serum rT3 concentration in hypothyroid or athyreotic patients receiving synthetic T4. Reverse Ts was detected in the serum of each of these patients, and this could not be attributed to contamination of proprietary T4 with rTs. The cross-reaction of proprietary Tt with rT3 antibody was found to be no more than that observed with reagent T4, and this was insufficient to explain the rT3 measured in serum of these patients. On the other hand, our findings were consistent with the thesis, suggested on the basis of a study of the metabolism of radioactive T4 (1) , that just as in the case of Ta, peripheral metabolism of T4 may also be an important source of rT3 in serum of man.
Study of Pronase digest of human Tg revealed the presence in it of rT3-like immunoreactive material in an amount approximately 1.4% that of T4. If 3,3'-T2 were present in human Tg in quantities approximately 14% that of T4, it could explain the finding of the observed amount of rTa in human Tg. However, until later studies can prove this to be the case, it would appear that in addition to peripheral metabolism of T4 (see above), thyroidal secretion may also be a source of rT3 in human serum.
The changes in serum rT3 values noted in hyper-or hypothyroid patients appeared similar to those observed in the case of T4 and/or T3 levels in serum of these patients, i.e., they were high-normal or clearly high in hyperthyroid patients, and low-normal or low in hypothyroid patients. The (Table IV) . As against serum rT3, serum T3 concentration in the newborn was comparable to that in hypothyroid patients. The serum Ts and To values in the cord sera reported here are comparable to those previously reported by others and by us (14, 28, 36) . The data on serum rT3 levels in the newborn are intriguing. They could signify that the peripheral metabolism of Ts may be different in the newborn than in the adult. It has already been suggested that peripheral conversion of T4 to Ts may be less in the newborn than in the adult (36) . The serum rT3 and T3 values in the present study would suggest that conversion of T4 to rT3 or to T3 may not occur randomly in the fetus, as has been suggested to be the case in the adult (1) and that conversion of To to rTs may be a major pathway of degradation of T4 at the time of birth. This in turn raises the question whether nonrandom conversion of T4 to rT3 and Ta might also occur under some conditions in adults. Obviously, studies in the newborn of the peripheral degradation and the thyroidal content of rT3 are necessary to validate these considerations. However, if the characteristics of the peripheral metabolism of T4 or T3, as well as the thyroidal content of T4 and T3, in the newborn are any indication of the changes in these parameters in the case of rT3, one could predict that the elevated cord serum rT3 is due mainly to a difference in metabolism of T4 in the newborn compared to the adult. Thus, the thyroidal content of T4 and T3 in the human term fetus is very similar to that in the adults (36) , and the peripheral degradation rate of T4 and T3 in the fetal sheep is not lower but much greater than that in the adult (37) .
Although the physiological significance of the conversion of T4 to Ts (2-8), a biologically more potent iodothyronine (38) , can be readily appreciated, the physiological function, if any, of the conversion of T4 to rT3, a relatively inert iodothyronine (39, 40) , remains unclear. rT3 has been shown to be capable of inhibiting the calorigenic effects of T4 as well as slowing its disappearance from the circulation (41) (42) (43) . These considerations lead one to suspect that rT3 may not be just an inactivation product of T4, but that it may be involved in physiological regulation of metabolism and biological action of T4. Additionally, it is tempting to consider that conversion of T4 to T3 and/or to rT3 may be physiologically regulated phenomena, similar to those proposed recently by DeLuca, Omdahl, and Tanaka for vitamin Ds (44) (45) (46) . These workers have made a fascinating discovery of two parallel enzyme systems in the kidney which lead to the conversion of 25-hydroxyvitamin D3 (25-OH-D3) to either biologically more active 1,25(OH)2-D3 or to a relatively biologically inert 24,25-(OH)2-D3. Generally, when 1,25-(OH)2-Ds production is diminished, 24,25-(OH)2-D3 production is increased (44) (45) (46) . In this respect, the findings of the present study, i.e., that serum rT3 is markedly elevated in the newborn whose serum T3 is markedly low, are similar. However, further study is needed to ascertain whether there is indeed an analogy between the metabolism of Ts and 25-OH-D3.
